Excess marks the spot: the FDA blows the whistle on abuses in new-drug ads.
D000329:Advertising / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000191:economics*; D011640:Public Policy; D014481:United States; D014486:United States Food and Drug Administration